Our and another independent study [37] demonstrate that SFRP2 is very frequently targeted by promoter methylation in human breast carcinomas as compared to normal human breast tissues, disposing breast cancer to the large number of human tumor entities for which SFRP2 methylation has already been described. This evidence concerns the gene SFRP2 and breast cancer.